These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 35836954)
1. Longitudinal Photoreceptor Phenotype Observation and Therapeutic Evaluation of a Carbonic Anhydrase Inhibitor in a X-Linked Retinoschisis Mouse Model. Liu M; Liu J; Wang W; Liu G; Jin X; Lei B Front Med (Lausanne); 2022; 9():886947. PubMed ID: 35836954 [TBL] [Abstract][Full Text] [Related]
2. Of men and mice: Human X-linked retinoschisis and fidelity in mouse modeling. Vijayasarathy C; Sardar Pasha SPB; Sieving PA Prog Retin Eye Res; 2022 Mar; 87():100999. PubMed ID: 34390869 [TBL] [Abstract][Full Text] [Related]
3. The dose-response relationship of subretinal gene therapy with rAAV2tYF-CB-h Hassan S; Hsu Y; Thompson JM; Kalmanek E; VandeLune JA; Stanley S; Drack AV Front Med (Lausanne); 2024; 11():1304819. PubMed ID: 38414621 [TBL] [Abstract][Full Text] [Related]
4. Retinoschisin gene therapy and natural history in the Rs1h-KO mouse: long-term rescue from retinal degeneration. Kjellstrom S; Bush RA; Zeng Y; Takada Y; Sieving PA Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3837-45. PubMed ID: 17652759 [TBL] [Abstract][Full Text] [Related]
5. XLRS Rat with Rs1 Ye EA; Zeng Y; Thomas S; Sun N; Smit-McBride Z; Sieving PA Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360232 [TBL] [Abstract][Full Text] [Related]
6. Investigating the role of Caspase-1 in a mouse model of Juvenile X-linked Retinoschisis. Gehrke EJ; Pandey A; Thompson J; Bhattarai S; Gurung P; Hsu Y; Drack AV Front Med (Lausanne); 2024; 11():1347599. PubMed ID: 38938378 [TBL] [Abstract][Full Text] [Related]
7. AAV2/4-RS1 gene therapy in the retinoschisin knockout mouse model of X-linked retinoschisis. Scruggs BA; Bhattarai S; Helms M; Cherascu I; Salesevic A; Stalter E; Laird J; Baker SA; Drack AV PLoS One; 2022; 17(12):e0276298. PubMed ID: 36477475 [TBL] [Abstract][Full Text] [Related]
8. Synaptic pathology in retinoschisis knockout (Rs1-/y) mouse retina and modification by rAAV-Rs1 gene delivery. Takada Y; Vijayasarathy C; Zeng Y; Kjellstrom S; Bush RA; Sieving PA Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3677-86. PubMed ID: 18660429 [TBL] [Abstract][Full Text] [Related]
9. An ex vivo gene therapy approach in X-linked retinoschisis. Bashar AE; Metcalfe AL; Viringipurampeer IA; Yanai A; Gregory-Evans CY; Gregory-Evans K Mol Vis; 2016; 22():718-33. PubMed ID: 27390514 [TBL] [Abstract][Full Text] [Related]
10. Rearing Light Intensity Affects Inner Retinal Pathology in a Mouse Model of X-Linked Retinoschisis but Does Not Alter Gene Therapy Outcome. Marangoni D; Yong Z; Kjellström S; Vijayasarathy C; A Sieving P; Bush RA Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1656-1664. PubMed ID: 28297725 [TBL] [Abstract][Full Text] [Related]
11. X-linked retinoschisis: RS1 mutation severity and age affect the ERG phenotype in a cohort of 68 affected male subjects. Bowles K; Cukras C; Turriff A; Sergeev Y; Vitale S; Bush RA; Sieving PA Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9250-6. PubMed ID: 22039241 [TBL] [Abstract][Full Text] [Related]
12. Differentiation of murine models of "negative ERG" by single and repetitive light stimuli. Tanimoto N; Akula JD; Fulton AB; Weber BH; Seeliger MW Doc Ophthalmol; 2016 Apr; 132(2):101-9. PubMed ID: 26996188 [TBL] [Abstract][Full Text] [Related]
13. Preclinical Dose-Escalation Study of Intravitreal AAV-RS1 Gene Therapy in a Mouse Model of X-linked Retinoschisis: Dose-Dependent Expression and Improved Retinal Structure and Function. Bush RA; Zeng Y; Colosi P; Kjellstrom S; Hiriyanna S; Vijayasarathy C; Santos M; Li J; Wu Z; Sieving PA Hum Gene Ther; 2016 May; 27(5):376-89. PubMed ID: 27036983 [TBL] [Abstract][Full Text] [Related]
14. A phenotype-genotype correlation study of X-linked retinoschisis. Vincent A; Robson AG; Neveu MM; Wright GA; Moore AT; Webster AR; Holder GE Ophthalmology; 2013 Jul; 120(7):1454-64. PubMed ID: 23453514 [TBL] [Abstract][Full Text] [Related]
15. In vivo imaging reveals novel aspects of retinal disease progression in Rs1h(-/Y) mice but no therapeutic effect of carbonic anhydrase inhibition. Zhour A; Bolz S; Grimm C; Willmann G; Schatz A; Weber BH; Zrenner E; Fischer MD Vet Ophthalmol; 2012 Sep; 15 Suppl 2():123-33. PubMed ID: 22672048 [TBL] [Abstract][Full Text] [Related]
16. Rod-driven OFF pathway responses in the distal retina: dark-adapted flicker electroretinogram in mouse. Lei B PLoS One; 2012; 7(8):e43856. PubMed ID: 22937111 [TBL] [Abstract][Full Text] [Related]
17. Retinal Structure and Gene Therapy Outcome in Retinoschisin-Deficient Mice Assessed by Spectral-Domain Optical Coherence Tomography. Zeng Y; Petralia RS; Vijayasarathy C; Wu Z; Hiriyanna S; Song H; Wang YX; Sieving PA; Bush RA Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT277-87. PubMed ID: 27409484 [TBL] [Abstract][Full Text] [Related]
18. ERG variability in X-linked congenital retinoschisis patients with mutations in the RS1 gene and the diagnostic importance of fundus autofluorescence and OCT. Renner AB; Kellner U; Fiebig B; Cropp E; Foerster MH; Weber BH Doc Ophthalmol; 2008 Mar; 116(2):97-109. PubMed ID: 17987333 [TBL] [Abstract][Full Text] [Related]
19. Juvenile X-linked retinoschisis with normal scotopic b-wave in the electroretinogram at an early stage of the disease. Eksandh L; Andréasson S; Abrahamson M Ophthalmic Genet; 2005 Sep; 26(3):111-7. PubMed ID: 16272055 [TBL] [Abstract][Full Text] [Related]
20. Abnormal cone structure in foveal schisis cavities in X-linked retinoschisis from mutations in exon 6 of the RS1 gene. Duncan JL; Ratnam K; Birch DG; Sundquist SM; Lucero AS; Zhang Y; Meltzer M; Smaoui N; Roorda A Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9614-23. PubMed ID: 22110067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]